Health ❯ Healthcare ❯ Medical Research

Cancer Treatment

Immunotherapy Pancreatic Cancer Breast Cancer Prostate Cancer Glioblastoma Lung Cancer Colorectal Cancer mRNA Vaccines Clinical Trials CAR T Cell Therapy

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Phase 2b data show lasting immune responses with reduced distant metastases as Phase 3 results are compiled to confirm clinical value.

Drug Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Gene Test Lets Many Over-40 Breast Cancer Patients Skip Chemotherapy

Mezigdomide Triplet Cuts Risk of Myeloma Progression by 52% in Phase 3 Trial

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

Study Finds Post-Diagnosis GLP-1 Use Linked to Lower Risk of Cancer Progression

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

Two-Session MRI-Guided Radiotherapy Matches Five Visits on Side Effects in Small Prostate Cancer Trial

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

CRISPR CD33-Deleted Stem Cell Transplant Shows Early Promise for AML and MDS

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

KRAS Pill Doubles Survival in Trial as Pancreatic Cancer Vaccine Advances

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

Pre-Surgery Pembrolizumab Shows Zero Relapses in MSI-High Bowel Cancer Trial

Exercise Beats Ibuprofen in Early Trial for Chemo Brain